This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

Janssen sues Hetero over generic HIV treatment


Janssen Products, a subsidiary of Johnson & Johnson, has sued Indian pharmaceutical company Hetero Drugs for applying to market a generic version of its HIV treatment Prezista.

Janssen, Tibotec, Johnson & Johnson, generic, Prezista, patent


Payment types accepted